Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Colonic Neoplasms × Axitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 56 Neoplasms 15 Kidney Neoplasms 15 Carcinoma, Non-Small-Cell Lung 10 Neoplasm Metastasis 9 Colorectal Neoplasms 8 Carcinoma, Hepatocellular 8 Melanoma 7 Glioblastoma 5 Carcinoma 5 Lung Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Uterine Cervical Neoplasms 3 Recurrence 3 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Thyroid Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Skin Neoplasms 2 Sarcoma 2 Pheochromocytoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Paraganglioma 2 Liver Neoplasms 2 Kidney Diseases 2 Carcinoma, Adenoid Cystic 2 Breast Neoplasms 2 Advanced Solid Tumors 2 cT2a N0NxM0 Renal Tumor 1

Interventions

Fluorouracil 218 Leucovorin 201 Oxaliplatin 190 Irinotecan 148 Bevacizumab 107 Capecitabine 92 Cetuximab 89 Folfox protocol 54 Chemotherapy, Adjuvant 34 Panitumumab 30 pembrolizumab 23 Nivolumab 22 Colonoscopy 22 Gemcitabine 19 Floxuridine 19 Magnetic Resonance Spectroscopy 18 IFL protocol 18 Celecoxib 18 Radiotherapy 17 Neoadjuvant Therapy 17 Early Intervention, Educational 17 Drug Therapy 17 Laparoscopy 14 Cyclophosphamide 14 Counseling 14 trifluridine tipiracil drug combination 13 regorafenib 13 XELOX 13 Erlotinib Hydrochloride 13 Biopsy 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04873895 2024-04-26

TACE-Ax-HCQ

Abramson Cancer Center at Penn Medicine

Phase 1 Terminated

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡